Metraipolis › archive › dc_734c11ea6e67

New biomarker in the early diagnosis of breast cancer: adiponectin, asprosin, adropin, and resistin — Europe PMC PMID:42174492

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42174492
DOI
10.1186/s12885-[numero omesso]-z
License (as archived)
solo-consultazione
Archived
2026-11-01T09:56:01.197Z
SHA-256 of the archived text
8d18bb9a4f5e36266598e5b249bc7f20c7cc34206d12d17a74818cb4050280e9
Stable URL of this page
https://metraipolis.com/documento/dc_734c11ea6e67

How to cite

New biomarker in the early diagnosis of breast cancer: adiponectin, asprosin, adropin, and resistin — Europe PMC PMID:42174492 — Europe PMC (en), https://europepmc.org/article/MED/42174492 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_734c11ea6e67 (Metraipolis archive dc_734c11ea6e67, sha256 8d18bb9a4f5e36266598e5b249bc7f20c7cc34206d12d17a74818cb4050280e9)
BibTeX
@misc{dc734c11ea6e67,
  title = {New biomarker in the early diagnosis of breast cancer: adiponectin, asprosin, adropin, and resistin — Europe PMC PMID:42174492},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42174492},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_734c11ea6e67; sha256 8d18bb9a4f5e36266598e5b249bc7f20c7cc34206d12d17a74818cb4050280e9},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42174492. Agents can read the archived copy with the MCP tool read_document.